论文部分内容阅读
脑血管病是中国居民死亡率最高的疾病,同时也是引起成人致残的最主要原因之一,其中高危非致残性脑血管病以其临床最常见、病情早期不稳定、复发风险高、及时治疗获益大等特点,近年来逐渐受到广泛关注。本项目组10余年来一直致力于寻找脑血管病的最佳干预人群、创新优化抗栓治疗方案、探寻个体化治疗新方法等,本文结合项目组取得的一系列研究结果,从高危非致残性脑血管病的早期高效识别、有效强化治疗新方案、个体化精准治疗新策略3方面内容对该类型脑血管病进行综述。
Cerebrovascular disease is one of the most common causes of death among Chinese residents. It is also one of the major causes of disability in adults. Among them, high-risk non-disabling cerebrovascular disease is the most common clinical condition, with unstable early stage, high risk of recurrence, Benefit of treatment and other characteristics, in recent years gradually widespread concern. For more than 10 years, the project team has been devoted to finding the best intervention group for cerebrovascular disease, innovating and optimizing the antithrombotic treatment plan and exploring new methods of individualized treatment. Based on a series of research results obtained by the project team, Cerebrovascular disease early and efficient identification of new programs to effectively strengthen the treatment of individual precise treatment of new strategies in three aspects of this type of cerebrovascular disease are reviewed.